Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Fairhaven MA, Norwich CT, York PA, East Syracuse NY,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05039632

Phase 1, Phase 2, Recruiting

Immune Profiling for Cancer Immunotherapy Response

for
Cancer, Tumor, Solid, Hematologic Malignancy, Blood Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18+

Code: NCT06116032

Recruiting

Revumenib in Combination With 7+3 + Midostaurin in AML

for
Acute Myeloid Leukemia, AML, Adult, AML With Gene Mutations,
Location: Boston MA, New Haven CT
Sponsor: Richard Stone, MD

Sex: All

Age: 18 - 70+

Code: NCT06313437

Phase 1, Recruiting

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06015932

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Vincere Biobank Research Protocol

for
Cancer
Location: Scottsdale AZ
Sponsor: Vincere Cancer Center

Sex: All

Age: 18+

Code: NCT05954299

Recruiting

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

for
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, Philadelphia PA, Baltimore MD, Columbus OH,
Sponsor: TopAlliance Biosciences

Sex: All

Age: 18+

Code: NCT04137900

Phase 1, Recruiting

Screening Strategies Among High-risk Populations for Anal Cancer

for
Neoplasms, HPV-Related Anal Squamous Cell Carcinoma
Location: Miami FL, Atlanta GA
Sponsor: Lisa Flowers

Sex: All

Age: 30 - 70+

Code: NCT06628570

Recruiting

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Los Angeles CA
Sponsor: Biostar Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05681000

Phase 1, Recruiting

LIFE Cancer Survivorship Database for Pediatric Cancer

for
Pediatric Cancer
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles

Sex: All

Age: 0+

Code: NCT01518400

Recruiting

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Toronto, Pittsburgh PA, Huntersville NC,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 18+

Code: NCT06480552

Phase 1, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: New Haven CT, New York NY, Montreal, Wynnewood PA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase 2, Recruiting

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

for
Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT05733000

Phase 2, Recruiting

Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood

for
Pediatric Cancer
Location: Montreal
Sponsor: St. Justine's Hospital

Sex: All

Age: 0 - 21

Code: NCT02242552

Recruiting

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

for
Metastatic Malignant Solid Neoplasm, Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05371132

Phase 1, Recruiting

A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Providence RI, Houston TX
Sponsor: TYK Medicines, Inc

Sex: All

Age: 18+

Code: NCT05769075

Phase 1, Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma
Location: Lake Success NY, Bronx NY, Columbus OH, Minneapolis MN,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT04565275

Phase 1, Phase 2, Recruiting

Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

for
Cervical Carcinoma, Fallopian Tube Carcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT06492070

Phase 2, Recruiting

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

for
Septic Shock, Sepsis, Pathologic Processes, Shock,
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05969275

Phase 2, Recruiting

Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment

for
Colorectal Cancer, Breast Cancer, Non Metastatic Cancer
Location: Sherbrooke
Sponsor: Université de Sherbrooke

Sex: All

Age: 40 - 70

Code: NCT06911970

Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial